S&P backs microfinance CDOs

The first deal, BlueOrchard Finance, was brought by Morgan Stanley for BlueOrchard, the microfinance and emerging-market manager. “The origins of the report lie in an increased level of inquiry by the market and coincides with the inaugural transaction, but what we are doing is looking at the bigger picture for this asset class,” said Gary Kochubka, director in emerging markets structured finance at Standard and Poor’s in New York. “There is still work to do with individual issuers, but the inputs are there.”

The rating agency said that it has three strong microfinance CDOs in the pipeline, one of which may price at the end of the year. The report points out that the loans exhibit resilient performance with low default rates. Most microfinance institutions, which lend to entrepreneurs in developing, non-investment grade-rated countries, report defaults in the 1-2% range. “An important factor will be the data provided by the MFI,” said Kochubka.

“There is room for improvement on the transparency and availability of information available to investors. MFI should start to get used to the difference from working with funding from multilaterals or philanthropic institutions that may not require the same level of management and best practices as is generally accepted in the institutional market,” Kochubka added.

As the market opens to traditional institutional investors such as pension funds and life insurers, the sector can be expected to grow beyond targeting the 100–200 top-tier microfinance institutions, which receive the majority of funding at present, to the second- and third-tier MFI. A secondary market may also grow out of the around 100 private funds that exist in the sector, allowing invest to divest shares and providing some liquidity to the market.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here